Challenges of subgroup analyses in multinational clinical trials: Experiences from the MERIT-HF trial

Authors:
  • DDDavid DeMets
    David DeMets
  • PDPrakash Deedwania
    Prakash Deedwania
  • BFBjörn Fagerberg
    Björn Fagerberg
  • SGSidney Goldstein
    Sidney Goldstein
  • SGStephen Gottlieb
    Stephen Gottlieb
  • AHAke Hjalmarson
    Ake Hjalmarson
  • JKJohn Kjekshus
    John Kjekshus
  • FWFinn Waagstein
    Finn Waagstein
  • JWJohn Wikstrand
    John Wikstrand

Abstract
No abstract available